Ligand Pharma Insider Sale: John Kozarich’s Strategic Divestiture Near 52‑Week High
Insightful analysis of Ligand Pharmaceuticals’ insider sales shows Kozarich’s disciplined sell‑off near a 52‑week high, hinting at future liquidity opportunities.
4 minutes to read